Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry|July 9, 2025
Synthesis of 2-(3-aminopropyl)benzopyrans as potential antipsychotic agents targeting D2/D3 and 5-HT2A receptorsÁlvaro Bernabeu-Sanchis, María José Varela, Ainhoa García, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
Synthesis of 2-Prenylated Alkoxylated Benzopyrans by Horner-Wadsworth-Emmons Olefination with PPARα/γ Agonist ActivityAinhoa García, Laura Vila, Paloma Marín, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2024
Synthesis of a new 2-prenylated quinoline as potential drug for metabolic syndrome with pan-PPAR activity and anti-inflammatory effectsCarlos Villarroel-Vicente, Ainhoa García, Khamis Zibar, et al.
Chemmedchem|January 31, 2026
Synthesis of Benzopyrans and Quinolines with Nitrogenated Chain and Their Cytotoxicity Against Human Cancer Cell LinesBernabeu-Sanchis Álvaro, Thomas A Mackenzie, Maria C Ramos, et al.
Bioorganic & Medicinal Chemistry|December 4, 2021
Synthesis and biological studies of "Polycerasoidol" and "trans-δ-Tocotrienolic acid" derivatives as PPARα and/or PPARγ agonistsLaura Vila, Nuria Cabedo, Carlos Villarroel-Vicente, et al.
Pharmacological Research|December 31, 2022
Anti-inflammatory effects and improved metabolic derangements in ob/ob mice by a newly synthesized prenylated benzopyran with pan-PPAR activityPatrice Marques, Carlos Villarroel-Vicente, Aida Collado, et al.
Bioorganic Chemistry|April 11, 2025
Development of 2- and 3-prenylated quinolines and tetrahydroquinolines with PPAR activity: From hit to lead and a novel pan-PPAR agonist as a potential candidate for metabolic syndromeCarlos Villarroel-Vicente, María Martínez-Solsona, Ainhoa García, et al.
Pageof 2